Zenebe Yosef, Akele Baye, W/Selassie Mulugeta, Necho Mogesie
Department of Psychiatry, Wollo University, Dessie, Ethiopia.
Department of Pharmacy, Wollo University, Dessie, Ethiopia.
Neuropsychiatr Dis Treat. 2023 Mar 28;19:673-687. doi: 10.2147/NDT.S377636. eCollection 2023.
Neurocognitive impairment (NCI) is one of the most common neurological complications in HIV-positive individuals, particularly in resource-limited countries. Neurocognitive impairments can occur at any stage of HIV infection, although the risk increases as the infection progresses. However, in Africa, there are few studies with highly variable and inconsistent results. Therefore, this study aimed to determine the prevalence and factors associated with NCI among HIV-positive people in Africa.
For this systematic review and meta-analysis, we used PubMed/Medline, Scopus, Web of Science, the Cochrane Library, Embase, and PsycINFO to comprehensively search a number of papers. Studies reporting the prevalence of NCI and its factors were included in the estimation of the pooled prevalence. A consistent data extraction format was created in Microsoft Excel to extract the data, which was then imported into STATA 11 statistical software for analysis. The heterogeneity was evaluated using the I2 test, and a random effect meta-analysis model was employed to calculate the pooled prevalence of NCI because the included studies showed significant heterogeneity.
In all, Africa had a pooled prevalence of NCI of 45.15% (95% CI: 36.86, 53.43). According to the subgroup analysis of this study, West Africa had the lowest frequency, at 42.40% (95% CI: 22.03, 62.77), whereas Central and South Africa had the highest prevalence, at 49.33% (95% CI: 10.72-87.95).
In Africa, the cumulative prevalence of NCI was high. Being a woman, not having a formal education, those with only an elementary education, being older, having late-stage HIV, and abusing drugs were all often associated with NCI. The average burden of NCI in Africa is high and that would be a significant figure for interventional actions in the area.
神经认知障碍(NCI)是HIV阳性个体中最常见的神经并发症之一,在资源有限的国家尤为如此。神经认知障碍可发生在HIV感染的任何阶段,尽管随着感染进展风险会增加。然而,在非洲,相关研究较少,结果差异很大且不一致。因此,本研究旨在确定非洲HIV阳性人群中NCI的患病率及其相关因素。
对于这项系统评价和荟萃分析,我们使用PubMed/Medline、Scopus、科学网、Cochrane图书馆、Embase和PsycINFO全面检索了多篇论文。报告NCI患病率及其相关因素的研究被纳入合并患病率的估计。在Microsoft Excel中创建了一致的数据提取格式来提取数据,然后将其导入STATA 11统计软件进行分析。使用I2检验评估异质性,由于纳入研究显示出显著异质性,因此采用随机效应荟萃分析模型计算NCI的合并患病率。
总体而言,非洲NCI的合并患病率为45.15%(95%置信区间:36.86, 53.43)。根据本研究的亚组分析,西非的患病率最低,为42.40%(95%置信区间:22.03, 62.77),而中非和南非的患病率最高,为49.33%(95%置信区间:10.72 - 87.95)。
在非洲,NCI的累积患病率很高。女性、未接受过正规教育、仅接受过小学教育、年龄较大、处于HIV晚期以及滥用药物都常常与NCI相关。非洲NCI的平均负担很高,这对于该领域的干预行动来说将是一个重要数字。